FIELD: medicine.
SUBSTANCE: invention relates to the use of a composition that contains an isolated IL-8-antibody as active substance that binds to human IL-8 for the treatment or prevention of IL-8-related disease selected from a group that consists of: endometriosis; adenomyosis; dysmenorrhea; adhesions; fibrotic diseases; pain with endometriosis, adenomyosis or dysmenorrhea; infertility and pain as a result of adhesions, fibrosis or inflammation.
EFFECT: obtaining a composition for the prevention or treatment of IL-8-related diseases.
4 cl, 42 dwg, 29 tbl, 25 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODY AGAINST IL-5, ITS ANTIGEN-BINDING FRAGMENT AND ITS MEDICAL USE | 2018 |
|
RU2772716C2 |
| FUSED SERPIN POLYPEPTIDES AND METHODS FOR USE THEREOF | 2019 |
|
RU2728861C1 |
| ANTI-IL-5 ANTIBODIES | 2017 |
|
RU2758008C2 |
| COMPOSITION FOR CULTURING NATURAL KILLER CELLS AND METHOD OF PRODUCING NATURAL KILLER CELLS USING SAME | 2020 |
|
RU2824216C1 |
| CD131-BINDING PROTEINS AND THEIR APPLICATIONS | 2016 |
|
RU2773927C2 |
| FUSED SERPIN POLYPEPTIDES AND METHODS FOR USE THEREOF | 2012 |
|
RU2698655C2 |
| THERAPEUTIC PRODUCT CONTAINING IL-33 ANTAGONIST FOR THE TREATMENT OF ENDOMETRIOSIS | 2018 |
|
RU2791705C2 |
| FUSED SERPINE POLYPEPTIDES AND METHODS OF THEIR APPLICATION | 2015 |
|
RU2746550C2 |
| ANTIBODY CAPABLE OF BINDING TO THYMIC STROMAL LYMPHOPOIETIN, AND USE THEREOF | 2020 |
|
RU2825304C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ANTI-IL-5 ANTIBODY, AND USE THEREOF | 2020 |
|
RU2824390C2 |
